1. Home
  2. OBT vs AKBA Comparison

OBT vs AKBA Comparison

Compare OBT & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBT
  • AKBA
  • Stock Information
  • Founded
  • OBT 1892
  • AKBA 2007
  • Country
  • OBT United States
  • AKBA United States
  • Employees
  • OBT N/A
  • AKBA N/A
  • Industry
  • OBT Major Banks
  • AKBA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OBT Finance
  • AKBA Health Care
  • Exchange
  • OBT Nasdaq
  • AKBA Nasdaq
  • Market Cap
  • OBT 352.3M
  • AKBA 336.2M
  • IPO Year
  • OBT N/A
  • AKBA 2014
  • Fundamental
  • Price
  • OBT $59.50
  • AKBA $1.88
  • Analyst Decision
  • OBT Buy
  • AKBA Strong Buy
  • Analyst Count
  • OBT 1
  • AKBA 2
  • Target Price
  • OBT $66.00
  • AKBA $5.75
  • AVG Volume (30 Days)
  • OBT 18.4K
  • AKBA 2.4M
  • Earning Date
  • OBT 10-30-2024
  • AKBA 11-07-2024
  • Dividend Yield
  • OBT 1.55%
  • AKBA N/A
  • EPS Growth
  • OBT N/A
  • AKBA N/A
  • EPS
  • OBT 5.11
  • AKBA N/A
  • Revenue
  • OBT $98,024,000.00
  • AKBA $169,879,000.00
  • Revenue This Year
  • OBT N/A
  • AKBA N/A
  • Revenue Next Year
  • OBT $4.78
  • AKBA $6.13
  • P/E Ratio
  • OBT $11.64
  • AKBA N/A
  • Revenue Growth
  • OBT 4.93
  • AKBA N/A
  • 52 Week Low
  • OBT $41.00
  • AKBA $0.80
  • 52 Week High
  • OBT $66.11
  • AKBA $2.48
  • Technical
  • Relative Strength Index (RSI)
  • OBT 52.45
  • AKBA 61.05
  • Support Level
  • OBT $57.12
  • AKBA $1.75
  • Resistance Level
  • OBT $60.00
  • AKBA $2.02
  • Average True Range (ATR)
  • OBT 2.31
  • AKBA 0.11
  • MACD
  • OBT -0.16
  • AKBA -0.02
  • Stochastic Oscillator
  • OBT 48.80
  • AKBA 60.00

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor, is approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: